vs

Side-by-side financial comparison of 4D Molecular Therapeutics, Inc. (FDMT) and MARINE PRODUCTS CORP (MPX). Click either name above to swap in a different company.

4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $64.6M, roughly 1.3× MARINE PRODUCTS CORP). 4D Molecular Therapeutics, Inc. runs the higher net margin — 22.8% vs 3.7%, a 19.1% gap on every dollar of revenue. On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs 35.0%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $4.1M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -3.5%).

4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.

West Marine is an American company based in Fort Lauderdale, Florida, which operates a chain of boating supply and fishing retail stores. The company has 247 retail stores in North America. West Marine also runs Blue Future a non profit organization. West Marine's flagship store is in Fort Lauderdale. Opened on November 11, 2011, the store is the company's largest at over 50,000 square feet.

FDMT vs MPX — Head-to-Head

Bigger by revenue
FDMT
FDMT
1.3× larger
FDMT
$85.1M
$64.6M
MPX
Growing faster (revenue YoY)
FDMT
FDMT
+8508865.0% gap
FDMT
8508900.0%
35.0%
MPX
Higher net margin
FDMT
FDMT
19.1% more per $
FDMT
22.8%
3.7%
MPX
More free cash flow
FDMT
FDMT
$24.3M more FCF
FDMT
$28.5M
$4.1M
MPX
Faster 2-yr revenue CAGR
FDMT
FDMT
Annualised
FDMT
5412.6%
-3.5%
MPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FDMT
FDMT
MPX
MPX
Revenue
$85.1M
$64.6M
Net Profit
$19.4M
$2.4M
Gross Margin
19.6%
Operating Margin
17.3%
5.8%
Net Margin
22.8%
3.7%
Revenue YoY
8508900.0%
35.0%
Net Profit YoY
139.1%
-44.6%
EPS (diluted)
$0.43
$0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FDMT
FDMT
MPX
MPX
Q4 25
$85.1M
$64.6M
Q3 25
$90.0K
$53.1M
Q2 25
$15.0K
$67.7M
Q1 25
$14.0K
$59.0M
Q4 24
$1.0K
$47.8M
Q3 24
$3.0K
$49.9M
Q2 24
$5.0K
$69.5M
Q1 24
$28.0K
$69.3M
Net Profit
FDMT
FDMT
MPX
MPX
Q4 25
$19.4M
$2.4M
Q3 25
$-56.9M
$2.6M
Q2 25
$-54.7M
$4.2M
Q1 25
$-48.0M
$2.2M
Q4 24
$4.3M
Q3 24
$-43.8M
$3.4M
Q2 24
$-35.0M
$5.6M
Q1 24
$-32.4M
$4.6M
Gross Margin
FDMT
FDMT
MPX
MPX
Q4 25
19.6%
Q3 25
19.2%
Q2 25
19.1%
Q1 25
18.6%
Q4 24
19.2%
Q3 24
18.4%
Q2 24
18.9%
Q1 24
20.2%
Operating Margin
FDMT
FDMT
MPX
MPX
Q4 25
17.3%
5.8%
Q3 25
-67983.3%
5.4%
Q2 25
-396373.3%
7.1%
Q1 25
-383007.1%
4.4%
Q4 24
7.7%
Q3 24
-1704400.0%
7.2%
Q2 24
-849120.0%
8.3%
Q1 24
-136200.0%
7.6%
Net Margin
FDMT
FDMT
MPX
MPX
Q4 25
22.8%
3.7%
Q3 25
-63195.6%
5.0%
Q2 25
-364386.7%
6.1%
Q1 25
-342657.1%
3.7%
Q4 24
8.9%
Q3 24
-1461433.3%
6.8%
Q2 24
-699060.0%
8.0%
Q1 24
-115717.9%
6.6%
EPS (diluted)
FDMT
FDMT
MPX
MPX
Q4 25
$0.43
$0.07
Q3 25
$-1.01
$0.07
Q2 25
$-0.98
$0.12
Q1 25
$-0.86
$0.06
Q4 24
$0.13
Q3 24
$-0.79
$0.10
Q2 24
$-0.63
$0.14
Q1 24
$-0.66
$0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FDMT
FDMT
MPX
MPX
Cash + ST InvestmentsLiquidity on hand
$402.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$505.7M
$125.0M
Total Assets
$566.7M
$147.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FDMT
FDMT
MPX
MPX
Q4 25
$402.7M
Q3 25
$305.1M
Q2 25
$293.2M
Q1 25
$321.4M
Q4 24
$424.9M
Q3 24
$501.9M
Q2 24
$541.9M
Q1 24
$525.9M
Stockholders' Equity
FDMT
FDMT
MPX
MPX
Q4 25
$505.7M
$125.0M
Q3 25
$369.0M
$126.3M
Q2 25
$420.9M
$127.2M
Q1 25
$469.7M
$126.4M
Q4 24
$510.6M
$129.0M
Q3 24
$552.9M
$128.8M
Q2 24
$588.3M
$129.3M
Q1 24
$600.6M
$151.4M
Total Assets
FDMT
FDMT
MPX
MPX
Q4 25
$566.7M
$147.2M
Q3 25
$424.0M
$179.5M
Q2 25
$473.6M
$173.2M
Q1 25
$515.7M
$182.9M
Q4 24
$560.4M
$171.2M
Q3 24
$604.0M
$176.3M
Q2 24
$620.1M
$175.7M
Q1 24
$629.9M
$204.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FDMT
FDMT
MPX
MPX
Operating Cash FlowLast quarter
$28.6M
$4.7M
Free Cash FlowOCF − Capex
$28.5M
$4.1M
FCF MarginFCF / Revenue
33.5%
6.4%
Capex IntensityCapex / Revenue
0.1%
0.9%
Cash ConversionOCF / Net Profit
1.47×
2.00×
TTM Free Cash FlowTrailing 4 quarters
$-109.9M
$14.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FDMT
FDMT
MPX
MPX
Q4 25
$28.6M
$4.7M
Q3 25
$-46.5M
$2.6M
Q2 25
$-43.4M
$-1.6M
Q1 25
$-47.8M
$10.8M
Q4 24
$-134.6M
$4.6M
Q3 24
$-29.4M
$5.1M
Q2 24
$-30.2M
$3.8M
Q1 24
$-29.1M
$15.9M
Free Cash Flow
FDMT
FDMT
MPX
MPX
Q4 25
$28.5M
$4.1M
Q3 25
$-46.6M
$2.1M
Q2 25
$-43.4M
$-2.0M
Q1 25
$-48.4M
$10.7M
Q4 24
$-138.4M
$3.6M
Q3 24
$-31.2M
$3.2M
Q2 24
$-30.6M
$3.0M
Q1 24
$-29.8M
$15.0M
FCF Margin
FDMT
FDMT
MPX
MPX
Q4 25
33.5%
6.4%
Q3 25
-51765.6%
4.0%
Q2 25
-289620.0%
-3.0%
Q1 25
-345635.7%
18.1%
Q4 24
-13837100.0%
7.6%
Q3 24
-1038966.7%
6.5%
Q2 24
-611840.0%
4.4%
Q1 24
-106421.4%
21.7%
Capex Intensity
FDMT
FDMT
MPX
MPX
Q4 25
0.1%
0.9%
Q3 25
101.1%
0.8%
Q2 25
440.0%
0.6%
Q1 25
4507.1%
0.2%
Q4 24
378600.0%
2.1%
Q3 24
59266.7%
3.8%
Q2 24
6980.0%
1.1%
Q1 24
2535.7%
1.3%
Cash Conversion
FDMT
FDMT
MPX
MPX
Q4 25
1.47×
2.00×
Q3 25
0.97×
Q2 25
-0.39×
Q1 25
4.88×
Q4 24
1.09×
Q3 24
1.51×
Q2 24
0.68×
Q1 24
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FDMT
FDMT

Segment breakdown not available.

MPX
MPX

Boats And Accessories$63.4M98%
Parts$1.1M2%

Related Comparisons